This is a Validated Antibody Database (VAD) review about human YTHDF3, based on 5 published articles (read how Labome selects the articles), using YTHDF3 antibody in all methods. It is aimed to help Labome visitors find the most suited YTHDF3 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
Abcam
domestic rabbit monoclonal (EPR21912-3)
  • western blot; human; loading ...; fig s4c
Abcam YTHDF3 antibody (Abcam, Ab220161) was used in western blot on human samples (fig s4c). Front Cell Dev Biol (2021) ncbi
domestic rabbit monoclonal (EPR21912-3)
  • western blot; human; loading ...; fig 2d
Abcam YTHDF3 antibody (Abcam, ab220161) was used in western blot on human samples (fig 2d). Cell Mol Biol Lett (2020) ncbi
domestic rabbit monoclonal (EPR21912-3)
  • immunocytochemistry; human; loading ...; fig 3g
  • western blot; human; 1:1000; loading ...; fig 3e
Abcam YTHDF3 antibody (Abcam, ab220161) was used in immunocytochemistry on human samples (fig 3g) and in western blot on human samples at 1:1000 (fig 3e). Mol Cancer (2020) ncbi
Santa Cruz Biotechnology
mouse monoclonal (F-2)
  • western blot; mouse; 1:500; loading ...; fig e1c
Santa Cruz Biotechnology YTHDF3 antibody (Santa-Cruz, sc-377119) was used in western blot on mouse samples at 1:500 (fig e1c). Nature (2019) ncbi
mouse monoclonal (F-2)
  • immunoprecipitation; human; loading ...; fig 3c
  • western blot; human; 1:500; loading ...; fig 4a
Santa Cruz Biotechnology YTHDF3 antibody (Santa Cruz, sc-377119) was used in immunoprecipitation on human samples (fig 3c) and in western blot on human samples at 1:500 (fig 4a). Cell Res (2017) ncbi
Articles Reviewed
  1. Hua Y, Zhang K, Sheng J, Ning Z, Li Y, Shi W, et al. NUCB1 Suppresses Growth and Shows Additive Effects With Gemcitabine in Pancreatic Ductal Adenocarcinoma via the Unfolded Protein Response. Front Cell Dev Biol. 2021;9:641836 pubmed publisher
  2. Ding H, Zhang X, Su Y, Jia C, Dai C. GNAS promotes inflammation-related hepatocellular carcinoma progression by promoting STAT3 activation. Cell Mol Biol Lett. 2020;25:8 pubmed publisher
  3. Jin D, Guo J, Wu Y, Yang L, Wang X, Du J, et al. m6A demethylase ALKBH5 inhibits tumor growth and metastasis by reducing YTHDFs-mediated YAP expression and inhibiting miR-107/LATS2-mediated YAP activity in NSCLC. Mol Cancer. 2020;19:40 pubmed publisher
  4. Han D, Liu J, Chen C, Dong L, Liu Y, Chang R, et al. Anti-tumour immunity controlled through mRNA m6A methylation and YTHDF1 in dendritic cells. Nature. 2019;566:270-274 pubmed publisher
  5. Shi H, Wang X, Lu Z, Zhao B, Ma H, Hsu P, et al. YTHDF3 facilitates translation and decay of N6-methyladenosine-modified RNA. Cell Res. 2017;27:315-328 pubmed publisher